Journal articles on the topic 'Antihelicobacter pyloli therapy'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 19 journal articles for your research on the topic 'Antihelicobacter pyloli therapy.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Tomilina, T.V. "Антиоксидантное действие оральных аппликаций кверцетинсодержащих гелей у крыс, получавших антихеликобактерную терапию = Antioxidant effect of gels containing quercetin which were applied orally to rats treated with antihelicobacter pyloli therapy". Journal of Education, Health and Sport 5, № 2 (2015): 179–86. https://doi.org/10.5281/zenodo.15993.
Full textUrazova, R. Z. "Treatment of inflammatory periodontal diseases in children infected with Helicobacter pylori." Kazan medical journal 82, no. 3 (2001): 208–9. http://dx.doi.org/10.17816/kazmj72140.
Full textShmatenko, O. P., та V. V. Osyodlo. "Рharmacoeconomic analysis of medical provision to servicemen with h. рylori associated chronic gastritis". Health of Society 9, № 5 (2021): 213–18. http://dx.doi.org/10.22141/2306-2436.9.5.2020.226950.
Full textPaliy, I. G., S. V. Zaika, and N. M. Kondratiuk. "Eradication of Helicobacter pylori: what determines the effectiveness antihelicobacter pharmacotherapy (according to the results of the analysis of urease breath tests performed in 2006-2019 in Vinnytsia region)." Reports of Vinnytsia National Medical University 26, no. 2 (2022): 191–201. http://dx.doi.org/10.31393/reports-vnmedical-2022-26(2)-04.
Full textAkkuratova, I. S., E. M. Spivak, and O. M. Manyakina. "Coinfection of gastric mucosa with Helicobacter Pylori and Epstein-Barr virus as a factor of ineffectiveness of antihelicobacter chronic gastritis therapy in adolescents." Perm Medical Journal 36, no. 1 (2019): 27–30. http://dx.doi.org/10.17816/pmj36127-30.
Full textParkhomenko, V. V., І. М. Skrypnyk, І. І. Starchenko, and O. F. Gopko. "CHARACTERISTICS OF GASTRIC MUCOSA INJURY IN PATIENTS WITH NSAID-INDUCED GASTROPATHY AND CONCOMITANT ISCHEMIC HEART DISEASE, AND WAYS TO CORRECT THIS CONDITION." Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії 20, no. 2 (2020): 70–75. http://dx.doi.org/10.31718/2077-1096.20.2.70.
Full textRIZAEV, Zhasur Alimdzhanovich, Lutfulla Saidullaevich MAKHMONOV, Abdugafar Gadaevich GADAEV, and Rustam Ismatullaevich TURAKULOV. "CHOICE OF THERAPY FOR IRON DEFICIENCY ANEMIA ASSOCIATED WITH HELICOBACTER PYLORI." Journal of biomedicine and practice 7, no. 5 (2022): 5. https://doi.org/10.5281/zenodo.7392766.
Full textFadieienko, G. D., and Y. V. Nikiforova. "Maastricht VI/Florence Consensus for the treatment of Helicobacter pylori infection: updated recommendations for cancer prevention opportunities." Modern Gastroenterology, no. 2 (April 30, 2023): 14–25. http://dx.doi.org/10.30978/mg-2023-2-14.
Full textBaryshnikova, N. V., M. D. Lovchikova, and I. I. Shishlova. "Molecular-genetic studies in the diagnosis of Helicobacter pylori infection." Medical alphabet, no. 34 (January 23, 2025): 27–34. https://doi.org/10.33667/2078-5631-2024-34-27-34.
Full textLiakh, Olesya I., Mariya A. Derbak, Yelyzaveta S. Sirchak, Mariana I. Tovt-Korshуnska, and Yana V. Lazur. "ASSESSMENT OF THE IMPACT OF ANTIREFLUX THERAPY ON THE COURSE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE." Wiadomości Lekarskie 74, no. 10 (2021): 2580–84. http://dx.doi.org/10.36740/wlek202110209.
Full textBaratova, D., and M. Baratova. "MULTIPLE MYELOMA AND HELICOBACTER PYLORI INFECTION DIAGNOSIS, TREATMENT AND PREVENTION." Scientific heritage, no. 132 (March 8, 2024): 26–30. https://doi.org/10.5281/zenodo.10795944.
Full textSorokman, T. V., P. M. Moldovan, N. Ya Cherneі, and N. O. Popelyuk. "The state of intestinal microbiocenosis in children with Helicobacter pylori-associated duodenal ulcer." CHILD`S HEALTH 16, no. 2 (2021): 116–21. http://dx.doi.org/10.22141/2224-0551.16.2.2021.229875.
Full textSirchak, Yelyzaveta S., Silviya V. Patskun, and Nelli V. Bedey. "DYNAMICS OF GASTRIN LEVEL IN PATIENTS WITH DIABETES MELLITUS 2 TYPE AND CHRONIC GASTRITIS AFTER HELICOBACTER PYLORI ERADICATION THERAPY." Wiadomości Lekarskie 73, no. 11 (2020): 2512–14. http://dx.doi.org/10.36740/wlek202011132.
Full textRusyaev, V. Yu, D. A. Sheptulin, N. V. Shulpekova, and Yu O. Shulpekova. "Rabeprazole in the treatment of duodenal ulcer desease and functional dyspepsia." Medical Council, no. 12 (July 29, 2018): 70–76. http://dx.doi.org/10.21518/2079-701x-2018-12-70-76.
Full textFadieienko, G. D., and S. V. Gridineva. "Cytoprotectant Doctovit: perspectives of the use at acid-dependent gastroduodenal diseases." Modern Gastroenterology, no. 3 (June 29, 2023): 43–48. http://dx.doi.org/10.30978/mg-2023-3-43.
Full textAkkuratova-Maksimova, I. S., O. M. Manyakina, and O. V. Shkolina. "Cellular composition of gastric glands in chronic gastritis among children." Perm Medical Journal 39, no. 1 (2022): 21–26. http://dx.doi.org/10.17816/pmj39121-26.
Full text"Сравнительная оценка эффективности 10-дневных схем эрадикации helicobacter pylori инфекции (тройной и тройной с добавлением висмута трикалия дицитрата)". Dalʹnevostočnyj medicinskij žurnal, № 4 (30 грудня 2019): 62–65. http://dx.doi.org/10.35177/1994-5191-2019-4-62-65.
Full textАфанасенкова, Т. Е., and Е. Е. Дубская. "The role of cycloferon in the treatment of chronic Helicobacter pylori-induced gastritis with gastric erosions associated with Epstein – Barr virus." Лечащий врач, no. 2(25) (February 19, 2022). http://dx.doi.org/10.51793/os.2022.25.2.002.
Full textBuzdugan, I. O., O. I. Fediv, S. V. Roborchuk, and L. О. Voloshyna. "Pathogenetic relationship and ways of correction of H. pylori in patients with gastric and duodenal peptic ulcers in the combination of arterial hypertension and type 2 diabetes mellitus. Treatment of patient with H. pylori in presence of toxicogenic stra." Ukrainian Therapeutical Journal, no. 1 (March 31, 2021). http://dx.doi.org/10.30978/utj2021-1-14.
Full text